Argentinian/Chilean validation of the Spanish-language version of Addenbrooke's Cognitive Examination III for diagnosing dementia
| Autor: | Teresa Torralva, A.R. Tagle, Loreto Olavarria, Patricia Lillo, María Roca, Andrea Slachevsky, N. Fiorentino, Patricia Flores, G. Bruno, D.S. Rueda, Diana Bruno |
|---|---|
| Rok vydání: | 2017 |
| Předmět: |
Male
medicine.medical_specialty Population Argentina Sensitivity and Specificity lcsh:RC346-429 03 medical and health sciences 0302 clinical medicine Cronbach's alpha Alzheimer Disease Internal medicine medicine Dementia Humans Cognitive Dysfunction Chile education lcsh:Neurology. Diseases of the nervous system Aged Language education.field_of_study business.industry Reproducibility of Results Cognition Translating medicine.disease Addenbrooke's cognitive examination Mental Status and Dementia Tests Test (assessment) Frontotemporal Dementia Female Alzheimer's disease business 030217 neurology & neurosurgery Frontotemporal dementia |
| Zdroj: | Neurología (English Edition), Vol 35, Iss 2, Pp 82-88 (2020) Neurología Artículos CONICYT CONICYT Chile instacron:CONICYT |
| ISSN: | 2173-5808 |
| Popis: | Background: The Addenbrooke's Cognitive Examination III (ACE-III), an adaptation of the ACE cognitive screening test, has been demonstrated to have high sensitivity and specificity in detecting cognitive impairment in patients with dementia and other neurological and psychiatric disorders. Although the Spanish-language version of the ACE-III has already been validated in Spain, it is yet to be validated in Latin America. The aim of this study was to validate the ACE-III test in an Argentinean and Chilean population. Methods: ACE-III was administered to 70 patients with Alzheimer disease, 31 patients with behavioural variant frontotemporal dementia, and a control group of 139 healthy volunteers. Participants were recruited at centres in both countries. Results: The Spanish-language version of ACE-III was found to have good internal consistency (Cronbach's alpha = 0.87). We found significant differences in total ACE-III scores between patients with Alzheimer disease and controls (P |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|